U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

D-87503

MORE DETAILS

AED3R32X41

Status:
Other
Class (Stereo):
CHEMICAL (ACHIRAL)

D-106669

MORE DETAILS

  9575Q08390

Status:
Other
Class (Stereo):
CHEMICAL (ACHIRAL)
Targets:
PI3-kinase p110-alpha subunit
41
Conditions:
Unknown
2596
D-106669 was investigated in frame of research program PI3K and MAPK inhibitors of AEterna Zentaris. D-106669 is a highly selective to class I of PI3K alpha (phosphatidylinositol 3-kinase) inhibitor.
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966